Cargando…
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Carboplatin and paclitaxel as doublet are the standard therapeutic option for advanced stage ovarian carcinoma in the first line as well as relapse. Carboplatin with its better toxicity profile has replaced cisplatin as the first line drug. However, increase in incidence of carboplatin hypersensitiv...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080656/ https://www.ncbi.nlm.nih.gov/pubmed/25006278 http://dx.doi.org/10.4103/0971-5851.133705 |